Placental dysfunction in Suramin-treated rats – a new model for pre-eclampsia
Authors:
- P. WentzelPWP. Wentzel
- S. LindebergSLS. Lindeberg
- T. NaessénTNT. Naessén
- L. JanssonLJL. Jansson
- M. OlovssonMOM. Olovsson
- U.J. ErikssonUEU.J. Eriksson
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Wax moth, Galleria mellonella fat body receptor for high‐density lipophorin (HDLp)Archives of Insect Biochemistry and Physiology, 2003
- Evaluation of a rat model of preeclampsia for HELLP syndrome characteristicsJournal of the Society for Gynecologic Investigation, 2003
- Increased circulating lipid peroxides in severe preeclampsia activate NF‐κΒ and upregulate ICAM‐1 in vascular endothelial cellsThe FASEB Journal, 2000
- 8-Iso-Prostaglandin F 2α Reduces Trophoblast Invasion and Matrix Metalloproteinase ActivityHypertension, 2000
- The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsiaJournal of Human Genetics, 2000
- Invasive Cytotrophoblasts Manifest Evidence of Oxidative Stress in PreeclampsiaThe American Journal of Pathology, 2000
- Maternal renal artery blood flow velocimetry in normal and hypertensive pregnanciesActa Obstetricia et Gynecologica Scandinavica, 1996
- Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic ratsTeratology, 1988
- Suramin in the treatment of AIDS: Mechanism of actionAntiviral Research, 1987
- Evidence that suramin and aurothiomalate are teratogenic in rat by disturbing yolk sac-mediated embryonic protein nutritionChemico-Biological Interactions, 1986